Pure follicle-stimulating hormone as an adjuvant therapy for selected cases in male infertility during in-vitro fertilization is beneficial

By Dirnfeld M.   Katz G.   Calderon I.   Abramovici H.   Bider D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 93, Iss. 1, 2000-11 ,pp. : 105-108

Elsevier

Access to resources Recommend Favorite

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment

By Casper F.W.   Seufert R.J.   Schaffrath M.   Pollow K.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 32-37

Elsevier

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction

By Daya S.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1100-1104

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism

By Bouloux P.   Warne D.W.   Loumaye E.   for the FSH Study Group in Male Infertility  

Fertility and Sterility, Vol. 77, Iss. 2, 2002-02 ,pp. : 270-273

Elsevier

Access to resources Recommend Favorite